CORREVIO PHARMA Stock Price (NASDAQ:CORV)

Add to My Stocks
$3.68 $0.02 (0.54%) CORV stock closing price Jun 22, 2018 (Closing)
Prev Close* : $3.7
Market Cap:
$129.01M
Day Low: $3.54
52 Week Low: $1.29
Open: $3.68
Volume: -
Day High: $3.8
52 Week High: $4.84
Dividend:
0.00

Latest Stock Market News

Latest Articles

CORREVIO PHARMA News - From Partners

New Strong Sell Stocks for April 14th   by Zacks on Apr 14, 2016
New Strong Sell Stocks for April 12th   by Zacks on Apr 12, 2016
New Strong Sell Stocks for March 21st   by Zacks on Mar 21, 2016
Cardiome Closes US$23 Million Bought Deal Financing   by Marketwired on Aug 13, 2015

CORV Stockcharts

View CORV PE ratio, PS ratio stocks charts and compare with peers.
CORV Chart
Note: Compare CORREVIO PHARMA stock price history with the index and industry peers.

CORREVIO PHARMA Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
5.04
PB ratio (
price to book ratio
)
6.04

CORREVIO PHARMA Returns

ROE
(return on equity)
-151%

CORREVIO PHARMA Financial Ratios

Asset Turnover
0.42
Receivables Turnover
4.09
Debt to Equity
4.31
Dividend Yield
0%

CORV Industry Peers

Company Price Change (%)
Adamis Pharma (ADMP)3.450.13 (3.63%)
Contrafect (CFRX)2.580.1 (4.03%)
Forward Pharma (FWP)2.790.01 (0.36%)
Otonomy (OTIC)4.20.15 (3.7%)
Johnson & Johnson (JNJ)122.841.39 (1.14%)
Arca Biopharma (ABIO)0.530.01 (1.92%)
Eli Lilly (LLY)85.920.15 (0.17%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
CASI Pharma (CASI)6.280.57 (9.98%)
Tesaro Inc (TSRO)49.623.87 (8.46%)
ACER THERAPEUTS (ACER)20.681.43 (7.43%)
Catalyst Pharma (CPRX)3.390.21 (6.6%)
Nature's Sunshine Products (NATR)9.250.45 (5.11%)
BioSpecifics Technologies (BSTC)43.912.01 (4.8%)
ChemoCentryx (CCXI)12.030.53 (4.61%)
Top gainers from Medical-Drugs industry
* As of Jun 23, 2018
CompanyPriceChange (%)
AVADEL PHARMA (AVDL)6.270.44 (6.56%)
Zogenix (ZGNX)44.72.85 (5.99%)
Nektar Therapeutics (NKTR)52.853.01 (5.39%)
MELINTA THERAPT (MLNT)7.10.35 (4.7%)
Adamis Pharma (ADMP)3.450.13 (3.64%)
BioCryst Pharma (BCRX)5.590.18 (3.12%)
Synergy Pharma (SGYP)1.890.06 (3.08%)
Top losers from Medical-Drugs industry
* As of Jun 23, 2018

CORREVIO PHARMA Financial Statements

income statement20172016201520142013
Net Sales or Revenues24M25.25M20.91M30.04M4.51M
Net Income-29.81M-19.61M-24.46M-18.22M4.77M
Total Operating Expense40.2M33.49M36.39M35.96M16.44M
View CORREVIO PHARMA income statement
balance sheet20172016201520142013
Total Assets66.81M67.05M48.63M50.11M47.33M
Total Liabilities50.62M33.03M28.69M32.97M24.68M
Shareholders Equity16.19M34.02M19.93M17.13M22.64M
View CORREVIO PHARMA balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.79M-1.62M1.26M--1.81M
Net Cash from (used by) Operating Activities-24.13M-15.98M-16.3M-18.52M-16.76M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.01M-0.13M-0.52M-0.03M
View CORREVIO PHARMA cash flow statement

CORREVIO PHARMA Stock Message Board